Aspira Women's Health Inc.
PrivateLast Round
Debt
Jul 1, 2026
Est. Valuation
$401.6M
Total Funding Raised
$127.17M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Aspira Women's Health Inc. is a healthcare diagnostics company that develops and commercializes AI-powered, non-invasive diagnostic tests for gynecologic diseases, including ovarian cancer and endometriosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aspira Women's Health Inc. Comparables
Compare Aspira Women's Health Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CpG Diagnostics, Inc. | 81% | |
| Cleo Diagnostics Ltd | 81% | |
| ClearNote Health | 80% |
Aspira Women's Health Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 1, 2026 | ||||
| Private Placement | Jun 5, 2026 | ||||
| Private Placement | Sep 18, 2025 | ||||
| Private Placement | Apr 8, 2025 | ||||
| Convertible Debt | Mar 11, 2025 | ||||
Private Placement | Jul 1, 2024 |
Aspira Women's Health Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amadeus Capital Partners | Series E |
| ROTH Capital Partners | Follow-on Offering |
| Alliance Global Partners | PIPE |
| OrbiMed | Series E |
| Morgan Stanley | Series E |
| Triton Funds | Private Placement |
| Atlas Venture | VC Round, Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2026
$1.05M debt round completed.
- Jun 5, 2026
$1.48M raised in a private placement round.
Aspira Women's Health Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aspira Women's Health Inc.'s valuation, stock price, and market status.
Is Aspira Women's Health Inc. a public or private company?
Aspira Women's Health Inc. is a private company.
What is the current stock price of Aspira Women's Health Inc.?
Aspira Women's Health Inc. is a private company, so its shares have no public market price. Caplight tracks Aspira Women's Health Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aspira Women's Health Inc. worth (valuation)?
Aspira Women's Health Inc.'s valuation is estimated at $401.6M based on funding round data.
Can I buy Aspira Women's Health Inc. stock?
Aspira Women's Health Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aspira Women's Health Inc.'s last funding round?
Aspira Women's Health Inc.'s most recent funding round was Debt on July 1, 2026.
Who are the main investors in Aspira Women's Health Inc.?
Key investors in Aspira Women's Health Inc. include Atlas Venture.
Will Aspira Women's Health Inc. IPO soon?
No public IPO plans have been announced for Aspira Women's Health Inc..
How can I track Aspira Women's Health Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Aspira Women's Health Inc.'s shares on secondary markets.